How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

18,348 results for

lead* NOT leading

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study

Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need (...) . >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study found significant examples of clinical leaders forging new modes of service design and delivery enabled by Clinical Commissioning Groups. {{author}} {{($index , , , & . John Storey 1, * , Richard Holti 1 , Jean Hartley 1 , Martin Marshall 2 , Tatum Matharu 1 1 The Open University Business School, The Open University, Milton Keynes, UK 2 Department of Applied Health Research, University College

2018 NIHR HTA programme

2. NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks a mixed-methods study

NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks a mixed-methods study NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks a mixed-methods study Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try (...) a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} This study explored knowledge networking and leadership in the context of the early development of Academic Health Science Networks and made recommendations for future research. {{author}} {{($index , , , , & . Ewan Ferlie 1, * , Davide Nicolini 2 , Jean Ledger 3 , Daniela D’Andreta 4 , Dmitrijs Kravcenko 5 , John de Pury 6 1 School of Management

2017 NIHR HTA programme

3. Chenodeoxycholic acid (Chenodeoxycholic acid Leadiant) The treatment of paediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukaemia in combination with chemotherapy.

Chenodeoxycholic acid (Chenodeoxycholic acid Leadiant) The treatment of paediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukaemia in combination with chemotherapy. Published 13 May 2019 Statement of advice SMC2190 chenodeoxycholic acid 250mg hard capsules (Chenodeoxycholic acid Leadiant®) Leadiant Biosciences 5 April 2019 ADVICE: in the absence of a submission from the holder of the marketing authorisation chenodeoxycholic acid (Chenodeoxycholic (...) acid Leadiant®) is not recommended for use within NHSScotland. Indication under review: for the treatment of inborn errors of primary bile acid synthesis due to sterol 27 hydroxylase deficiency (presenting as cerebrotendinous xanthomatosis) in infants, children and adolescents aged 1 month to 18 years and adults. The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland. Advice

2019 Scottish Medicines Consortium

4. Assessment of the LEADER study on liraglutide - rapid report

Assessment of the LEADER study on liraglutide - rapid report 1 Translation of the executive summary of the rapid report Bewertung der Studie LEADER zu Liraglutid (Version 1.0; Status: 23 August 2017). Please note: This translation is provided as a service by IQWiG to English-language readers. However, solely the German original text is absolutely authoritative and legally binding. Executive Summary IQWiG Reports – Commission No. A17-09 Assessment of the LEADER study on liraglutide 1 Executive (...) summary of rapid report A17-09 Version 1.0 Assessment of the LEADER study on liraglutide 23 August 2017 Institute for Quality and Efficiency in Health Care (IQWiG) - i - Publishing details Publisher: Institute for Quality and Efficiency in Health Care Topic: Assessment of the LEADER study on liraglutide Commissioning agency: Federal Joint Committee Commission awarded on: 8 March 2017 Internal Commission No.: A17-09 Address of publisher: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen

2017 Institute for Quality and Efficiency in Healthcare (IQWiG)

5. Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study

Despite the variation in practice, we found significant examples of clinical leaders forging new modes of service design and delivery. A great deal of the service redesign effort was directed at compensating for the fragmented nature of the NHS – part of which had been created by the 2012 reforms. This is the first study to reveal details of such work in a systematic way. Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Humans; Leadership Language Published English Country (...) Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study Clinical leadership in service redesign using Clinical Commissioning Groups: a mixed-methods study Storey J, Holti R, Hartley J, Marshall M & Matharu T Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality

2018 Health Technology Assessment (HTA) Database.

6. [Assessment of the LEADER study on liraglutide - rapid report]

[Assessment of the LEADER study on liraglutide - rapid report] Bewertung der studie LEADER zu liraglutid: rapid report; auftrag A17-09 [Assessment of the LEADER study on liraglutide - rapid report] Bewertung der studie LEADER zu liraglutid: rapid report; auftrag A17-09 [Assessment of the LEADER study on liraglutide - rapid report] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record of a published health technology assessment from (...) a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Bewertung der studie LEADER zu liraglutid: rapid report; auftrag A17-09. [Assessment of the LEADER study on liraglutide - rapid report] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 530. 2017 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH

2018 Health Technology Assessment (HTA) Database.

7. Leadership vacancies in the NHS

Leadership vacancies in the NHS Leadership vacancies in the NHS | The King's Fund Main navigation Health and care services Leadership, systems and organisations Patients, people and society Policy, finance and performance Search term Apply Leadership vacancies in the NHS This content relates to the following topics: Share this content Related details Authors Suzie Bailey Saffron Cordery Senior NHS leaders enjoy highly rewarding but increasingly challenging roles. highlights the cocktail (...) of financial and operational challenges they face and the pressures caused by the unrelenting media and political attention on the NHS. Despite the positive press around NHS 70, this often sees leaders portrayed negatively, particularly those from managerial rather than clinical backgrounds. It’s not all bad news. The average tenure for a trust CEO is up to three years from two and a half in 2014. But this is still too short and the turnover in the executive director posts we looked at is very concerning

2018 The King's Fund

8. NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks a mixed-methods study

' strategies and practices of knowledge mobilisation in their formative phase, when they were building up health- and wealth-related networks; and (2) to investigate how knowledge leadership took place in these settings and the characteristics of people perceived as knowledge leaders (KLs). Specific research objectives operationalised these broad aims. Authors' conclusions The study's results have implications for (1) AHSN knowledge mobilisation strategies and networks, (2) the shape of AHSN regional (...) NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks a mixed-methods study NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks a mixed-methods study NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks a mixed-methods study Ferlie E, Nicolini D, Ledger J, D'Andreta D, Kravcenko D & de Pury J Record Status

2017 Health Technology Assessment (HTA) Database.

9. Building resilience and sustainability – tips for charity leaders

Building resilience and sustainability – tips for charity leaders Building resilience and sustainability – tips for charity leaders | The King's Fund Main navigation Health and care services Leadership, systems and organisations Patients, people and society Policy, finance and performance Search term Apply Building resilience and sustainability – tips for charity leaders This content relates to the following topics: Part of Jump link block Jump to section Share this content Charities (...) Awards offer, and so we have produced this paper to share some of the knowledge and feedback we have gained over the years. See a brief visual summary below, or scroll down to read the full feature. 10 tips for charity leaders: visual summary Take time to reflect and learn: a necessity not a luxury Although charities recognise that developing their leadership skills is important, leaders sometimes feel there are too many other demands on their time or resources to justify investing in themselves. One

2017 The King's Fund

10. Talking leadership

Talking leadership Talking leadership | The King's Fund Main navigation Health and care services Leadership, systems and organisations Patients, people and society Policy, finance and performance Search term Apply Talking leadership: transforming mental health services This content relates to the following topics: Share this content This month we're talking leadership with Mandip Randhawa about the challenges of transforming mental health services for children and young people. Mandip (...) is a consultant in the leadership and organisational development team at The King's Fund, who has been on secondment at Forward Thinking Birmingham for the past 18 months. Tell us a bit about the work you have been involved in? Traditionally, mental health services for young people are delivered by child and adolescent mental health services (CAMHS) up until the age of 16 or 18 – or when a young person leaves school or college – at which point they’re expected to transition to adult mental health services

2017 The King's Fund

11. Mapping and analysis of capacity building initiatives on human resources for health leadership

Mapping and analysis of capacity building initiatives on human resources for health leadership Mapping and analysis of capacity building initiatives on human resources for health leadership JavaScript is disabled for your browser. Some features of this site may not work without it. Toggle navigation Toggle navigation Search Browse Statistics Related Links Mapping and analysis of capacity building initiatives on human resources for health leadership View/ Open Rights View Statistics Altmetrics (...) Share Citation World Health Organization . (‎2017)‎. Mapping and analysis of capacity building initiatives on human resources for health leadership. World Health Organization. . License: CC BY-NC-SA 3.0 IGO Relation Human Resources for Health Observer Series;23 Description 30 p. ISBN 9789241513210 Collections Language English Metadata Related items Showing items related by title and MeSH subject.  Всемирная ассамблея здравоохранения, 54 сессия (‎ WHA54.13 , 2001 )‎  World Health Assembly, 64

2017 WHO

12. Talking leadership: Mark Redhead on the Top Manager Programme

Talking leadership: Mark Redhead on the Top Manager Programme Talking leadership: Mark Redhead on the Top Manager Programme | The King's Fund Main navigation Health and care services Leadership, systems and organisations Patients, people and society Policy, finance and performance Search term Apply Talking leadership: Mark Redhead on the Top Manager Programme This content relates to the following topics: Share this content is Head of Strategy and Planning at the Royal Free London NHS Foundation (...) with challenges in your current role? I work in planning for the Royal Free London, a large acute trust. We are currently implementing a new ‘group’ structure – or acute care collaboration in new care models/vanguard terminology. One of my main challenges is setting up a new structure and process for planning as we implement group governance: this needs to work for the group overall, for site leadership, for clinical directorates and for our new clinical practice groups which will bring together clinicians

2017 The King's Fund

13. Collective action for knowledge mobilisation: a realist evaluation of the Collaborations for Leadership in Applied Health Research and Care

Collective action for knowledge mobilisation: a realist evaluation of the Collaborations for Leadership in Applied Health Research and Care Collective action for knowledge mobilisation: a realist evaluation of the Collaborations for Leadership in Applied Health Research and Care Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from

Full Text available with Trip Pro

2015 NIHR HTA programme

14. Delivering the aims of the Collaborations for Leadership in Applied Health Research and Care: understanding their strategies and contributions

Delivering the aims of the Collaborations for Leadership in Applied Health Research and Care: understanding their strategies and contributions Delivering the aims of the Collaborations for Leadership in Applied Health Research and Care: understanding their strategies and contributions Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from

Full Text available with Trip Pro

2015 NIHR HTA programme

15. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial

Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial To explore gallbladder- and biliary tract-related events reported for the liraglutide and placebo groups in the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial.LEADER was an international, randomized, double-blind, controlled cardiovascular (CV (...) patients (HR 1.56; 95% CI 1.10, 2.20; P = 0.013) but for similar proportions of the patients who experienced gallbladder- or biliary tract-related events (57% with liraglutide vs. 59% with placebo).Although LEADER was not specifically designed to assess acute gallbladder or biliary disease, the trial showed an increased risk of gallbladder- or biliary tract-related events with liraglutide versus placebo, which appeared to be consistent across four categories of these events. Further studies should

Full Text available with Trip Pro

2019 EvidenceUpdates

16. Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)

Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial) Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (From the GLOBAL LEADERS Trial) - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other (...) characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Am J Cardiol Actions , 124 (12), 1833-1840 2019 Dec 15 Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (From the GLOBAL LEADERS Trial) , ... Expand Authors

2019 EvidenceUpdates

17. Pilot study of a training program to enhance transformational leadership in Spinal Cord Injury Peer Mentors. (PubMed)

Pilot study of a training program to enhance transformational leadership in Spinal Cord Injury Peer Mentors. Experimental, pragmatic design.(1) To determine the effects of a transformational leadership (TFL) training program on spinal cord injury (SCI) peer mentors and their mentees; (2) To document characteristics of mentorship within a community-based SCI peer mentor program.In total 23 SCI peer mentors (70% male; M age = 47.4 ± 12.1) were randomly allocated to an Experimental or Control

Full Text available with Trip Pro

2018 Spinal cord series and cases Controlled trial quality: uncertain

18. Using opinion leaders to address intervention gaps in concussion prevention in youth sports: key concepts and foundational theory (PubMed)

Using opinion leaders to address intervention gaps in concussion prevention in youth sports: key concepts and foundational theory Behavioral interventions to increase disclosure and proper management of concussion in youth sports have unrealized potential when it comes to preventing concussion. Interventions have focused on changing individual athlete behavior and have fallen short of the potential for sustained systemic behavioral change. One potentially critical reason for this shortfall (...) is that other key determinants of risk behaviors at all levels of the socio-ecological model (e.g. interpersonal, community, policy) are not addressed in extant programming. There is a critical need for theory-driven interventions that address concussion prevention and education at the community level and target sustainable culture change. The Popular Opinion Leader (POL) intervention, a multi-level intervention model previously successfully employed in multiple public health contexts, is theoretically well

Full Text available with Trip Pro

2018 Injury epidemiology

19. ESMO Leaders Generation Programme: an alumni insight (PubMed)

ESMO Leaders Generation Programme: an alumni insight 29464107 2018 02 21 2059-7029 3 1 2018 ESMO open ESMO Open ESMO Leaders Generation Programme: an alumni insight. e000312 10.1136/esmoopen-2017-000312 Arruda Leticia De Mattos LM Department of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain. Criscitiello Carmen C Division of Early Drug Development, European Institute of Oncology, Milano, Italy. Lambertini Matteo M Department of Medicine, Institut (...) Jules Bordet and Université Libre de Bruxelles (ULB), Brussels, Belgium. Argiles Guillem G Department of Medical Oncology, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain. eng Journal Article 2018 01 29 England ESMO Open 101690685 2059-7029 Esmo Leaders Generation Programme 2017 12 13 2017 12 13 2018 2 22 6 0 2018 2 22 6 0 2018 2 22 6 1 epublish 29464107 10.1136/esmoopen-2017-000312 esmoopen-2017-000312 PMC5812397

Full Text available with Trip Pro

2018 ESMO open

20. Report on the status of women occupying leadership roles in oncology (PubMed)

Report on the status of women occupying leadership roles in oncology While the global workforce is approaching gender parity, women occupy a small number of management level positions across most professions, including healthcare. Although the inclusion of women into the membership of many oncology societies has increased, the under-representation of women in leadership roles within international and national oncology societies remains relatively consistent. Moreover, the exact status of women (...) of a gender gap within oncology. Results regarding the under-representation of women occupying leadership roles in oncology show female participation as members of the board or presidents of national and international oncology societies and as invited speakers at oncology congresses remains below 50% in the majority of societies included in this analysis. Women in leadership positions of societies was associated with a higher percentage of female invited speakers at these societies' congresses (p=0.006

Full Text available with Trip Pro

2018 ESMO open

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>